Clorox Q3 sales fall 8% to $1.67B; adjusted EPS down 15% to $1.45; outlook cautious

CLOROX CO /DE/

2025-Q3 EPS reported $3.84 vs consensus $0.79 ▲ beat (+383.3%)

Net sales $1.67B, down 8% (organic -2%) on category slowdowns and unfavorable price mix.
Gross margin expanded 240 bps to 44.6% (10th consecutive quarter), driven by cost savings and divestitures.
GAAP diluted EPS $1.50 (up 466% from -$0.41) includes lapped Argentina loss and cyber insurance recoveries.
Adjusted EPS $1.45 (down 15% from $1.71) on lower sales, partially offset by higher gross margin.
CEO expects Q4 headwinds to persist; still forecasts organic sales growth and strong earnings growth for FY25.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.